News for Elanco Animal Health Inc (5EA.DE)

Introduction to the Transaction On February 28, 2025, FMR LLC (Trades, Portfolio), a prominent investment firm, made a significant addition to its portfolio by

Elanco Animal Health Inc (ELAN) showcases a robust portfolio with top products contributing to 36% of total revenue.Strategic acquisitions and R&D efforts posi

Shares of Elanco Animal Health Inc (ELAN) surged 5.79% in mid-day trading on Feb 26. The stock reached an intraday high of $11.47, before settling at $11.32,

Revenue: $1.02 billion in Q4, representing a 1% reported decline; 4% organic constant currency growth.Adjusted EBITDA: $177 million in Q4, an increase of $12 m

Feb 25, 2025 / 01:00PM GMTOperator Ladies and gentlemen, thank you for standing by. Welcome to Elanco Animal Health's fourth quarter 2024 earnings conference ca

Summary Elanco Animal Health Inc (ELAN) announced on February 25, 2025, a strategic partnership with Medgene, a South Dakota-based company, to commercialize a h

Shares of Elanco Animal Health Inc (ELAN) fell 4.23% in mid-day trading on Feb 25. The stock reached an intraday low of $10.20, before recovering slightly to

Elanco Animal Health Inc (ELAN) released its financial results for the fourth quarter and full year 2024 on February 25, 2025. The company reported a slight dec

Revenue: Achieved $1,020 million in Q4 2024, surpassing the estimated $1,010.10 million, despite a 1% decrease on a reported basis.Net Loss: Reported a net los

Summary Elanco Animal Health Inc (ELAN), a global leader in animal health, announced on February 21, 2025, that it will participate in several upcoming investor

On December 31, 2024, Magnetar Financial LLC (Trades, Portfolio) made a strategic move by acquiring 35,648.5 shares of Wheeler Real Estate Investment Trust Inc

Shares of Elanco Animal Health Inc (ELAN) fell 3.82% in mid-day trading on Feb 14. The stock reached an intraday low of $10.77, before recovering slightly to

On December 31, 2024, FMR LLC (Trades, Portfolio), a prominent investment firm, executed a significant transaction involving Elanco Animal Health Inc (ELAN). Th

Elanco Animal Health Inc (ELAN) announced on January 27, 2025, the launch of Zenrelia, a new FDA-approved oral JAK inhibitor designed to treat pruritus and atop

Elanco Animal Health Inc (ELAN) has released a press statement on January 10, 2025, highlighting the transformative power of "Unreasonable Hospitality" in leade

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a...

Shares of Elanco Animal Health Inc (ELAN) fell 5.49% in mid-day trading on Dec 3. The stock reached an intraday low of $12.69, before recovering slightly to $

SAN FRANCISCO, Nov. 30, 2024 (GLOBE NEWSWIRE) -- A federal lawsuit has been filed in the U.S. District Court of Maryland against Elanco Animal Health Inc. and

ELAN Investors with Losses Encouraged to Contact the Firm Before Dec. 6, 2024 Deadline SAN FRANCISCO, Nov. 27, 2024 (GLOBE NEWSWIRE) -- A federal lawsuit ha